NPRA approves clinical study of another Covid-19 vaccine from China
Health director-general Tan Sri Dr Noor Hisham Abdullah said the clinical study will involve the SARS-CoV-2 vaccine (Vero Cells), inactivated, manufactured by Shenzhen Kangtai Biological Products Co Ltd in China.